Ke Xiang Zhou
Direktor/Vorstandsmitglied bei BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Aktive Positionen von Ke Xiang Zhou
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Direktor/Vorstandsmitglied | 12.03.2018 | - |
| Cmbi Capital Management Shenzhen Co. Ltd. | Vorstandsvorsitzender | 01.12.2015 | - |
Xiamen LP Pharmaceutical Co., Ltd.
 Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Karriereverlauf von Ke Xiang Zhou
Ehemalige bekannte Positionen von Ke Xiang Zhou
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Eucure Beijing Biopharma Co Ltd | Direktor/Vorstandsmitglied | 01.02.2018 | 01.08.2021 |
Apollomics, Inc. (United States)
 Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Direktor/Vorstandsmitglied | 27.12.2018 | - |
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Direktor/Vorstandsmitglied | 24.03.2018 | - |
Ausbildung von Ke Xiang Zhou
| Peking University Health Science Center | Doctorate Degree |
| Southern Medical University | Undergraduate Degree |
Statistik
International
| China | 8 |
| Cayman Islands | 2 |
Operativ
| Director/Board Member | 5 |
| Doctorate Degree | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD. | Health Technology |
| BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD. | Commercial Services |
| Private Unternehmen | 4 |
|---|---|
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Health Technology |
| Cmbi Capital Management Shenzhen Co. Ltd. | |
Xiamen LP Pharmaceutical Co., Ltd.
Xiamen LP Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Xiamen LP Pharmaceutical Co., Ltd. engages in the development of improved new drugs. It provides perfluoropropane human albumin microspheres for injection, pramipexole hydrochloride sustained-release tablets, and clonidine hydrochloride sustained-release tablets. The company was founded by Ying Ye and Cheng Ye on November 2, 2012 and is headquartered in Xiamen, China. | Commercial Services |
| Eucure Beijing Biopharma Co Ltd |
- Börse
- Insiders
- Ke Xiang Zhou
- Erfahrung
